1.15Open1.15Pre Close0 Volume10 Open Interest25.00Strike Price0.00Turnover150.49%IV28.70%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry1.15Extrinsic Value100Contract SizeAmericanOptions Type-0.1568Delta0.0203Gamma29.09Leverage Ratio-0.0702Theta-0.0033Rho-4.56Eff Leverage0.0189Vega
XOMA Corp Stock Discussion
XOMA Royalty Acquires 50% of Twist Bioscience's Royalty, Milestone Economics for $15M
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...
$Dyne Therapeutics (DYN.US)$ 4% Closing of public offering
$Geron (GERN.US)$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (ZEAL.US)$ 2% Capital increase
$XOMA Corp (XOMA.US)$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences (CLRB.US)$ 1% Topline results @ conf. call
$CytomX (CTMX.US)$ 0% Present @ B. Riley Sec. Conf. '24
No comment yet